Our results also begin to shed light on the molecular underpinnings by which STAT3 contributes to AD and CAA pathology, including providing evidence that STAT3 (1) impacts APP processing through BACE1 activity, and (2) induces oxidative stress that alters LRP-1 expression. Here, BACE1 is linked to Alzheimer disease.